A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
Clinical trial NCT05832151 · COMPLETED
Trial details
- NCT number
- NCT05832151
- Sponsor
- CinDome Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2025-11-14
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.